Author:
De Amici, M 1; Mariani, F 2; Corsico, AG 2; Piloni, D 2; Paracchini, E 2; Torre, C 1; Nigrisoli, S 1; Campo, I 2; Marseglia, GL 1
Author address:
1 Foundation IRCCS Policlinico San Matteo, Department of Pediatrics, Pavia, Italy; 2
Foundation IRCCS Policlinico San Matteo, Department of Pneumology, Pavia, Italy
Full conference title:
European Academy of Allergy and Clinical Immunology Congress 2015
Date: 5 August 2020
Abstract:
Background: Aspergillus may cause a variety of pulmonary diseases, depending on immune status and the presence of underlying lung disease. Aspergilloma is mainly seen in patients with cavitary lung disease, while allergic bronchopulmonary aspergillosis is described in patients with hypersensitivity to Aspergillus antigens. Definitive diagnosis of fungal disease is often difficult, when culture is negative. The detection of specific IgE may enable clinicians to select the best strategy for managing the disease. Therefore the detection of IgG and IgG4 is considered a marker for exposure in some lung diseases. Aim of this study is to demonstrate the validity of specific IgE and IgG in pulmonary fungal disease diagnosis.
Method: Two hundred and seventeen patients with a possible pulmonary aspegillosis have been evaluated. Serum levels of specific IgE were measured by immunofluorometric assay and expressed in kU/L. Values higher than 0.35 kU/L were considered positive. Serum levels of IgG were measured by immunofluorometric assay and expressed in mgA/L. Values higher than 25 mgA/L indicate a probable sensitization while values in the range 8–25 mgA/L indicate a risk. Aspergillus Fumigatus (AF) was isolated in 36 patients; 10 of them had positive specific IgE to AF. IgG to AF showed that 9 patients were a risk and 23 with a probable sensitization. Aspergillus Niger (AN) was isolated in other 36 patients; 6 of them had positive specific IgE to AN. IgG to AN showed that 10 patients were a risk and 15 with a probable sensitization.
Results: In our preliminary data, IgE specific antibodies level are significantly different between positive and negative coltures of Aspergillus Fumigatus (p = 0.045) and Aspergillus Niger (p = 0.048). IgG and IgG4 levels show a significant difference between positive and negative coltures of Aspergillus Fumigatus (respectively p = 0.0062 and p = 0.0015) but not for Aspergillus Niger (respectively p = 0.059 and p = 0.1241). Moreover specific IgE levels resulted significantly different also comparing A. Fumigatus with A. Niger in positive(p = 0.0001)and in negative coltures (p < 0.0001), with higher values of AF. Also IgG and IgG4 values showed a significant difference between AF and AN in positive (respectively p = 0.0074 and p = 0.0001) and negative coltures (both p < 0.0001), with higher values of AF.
Conclusion: Specific IgE serum levels and IgG serum levels seem to be serologic tests that could potentially predict the pulmonary fungal disease.
Abstract Number: 1247
Link to conference website:
Link Conference abstract:
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Jarod Fortwendel (US)
2024
49
n/a
-
v
Dr Takashi Umeyama (JP)
2024
48
n/a
-
v
Baptiste Bidon, Hajar Yaakoub, Arnaud Lanoue, Antoine Géry, Virginie Séguin, Claire Hoffmann Solène Le Gal, Gilles Nevez, Vincent Courdavault, Jean-Philippe Bouchara, Antonis Rokas, Gustavo H. Goldman, Jean-Pierre Gangneux, Jens C. Frisvad, Domenico Davolos, David Garon, Nicolas Papon
2024
47
n/a
-
v
Adela Martin-Vicente (US)
2024
46
n/a
-
v
Antonio Inforzato (IT)
2024
45
n/a
-
v
Takahiro Takazono (JP)
2024
44
n/a
-
v
Laurence Delhaes (FR)
2024
43
n/a
-
v
Dr Sarah Ahmed (NL)
2024
42
n/a